. Characteristics by number of high inflammatory markers in the control group……….18 Table 3 . WHI. Risk ratios (95% CI's) of hip fracture according to quartiles of cytokine soluble receptor concentrations among the controls……………………………………………………..20 Table 4 . Risk ratios (95% CIs Receptor Activated Nuclear Factor-kB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and decrease osteoprotegerin (OPG) production resulting in increased activation of osteoclasts. (10) In the second physiological pathway, estrogen deficiency results in cytokine mediated osteoclast activation. (11, 12) The association between pro-inflammatory markers and hip fractures is uncertain. A prior prospective study showed that elevated inflammatory markers are a risk factor for incident fractures. (13) H owever, this prior study included all non-traumatic fractures (N= 156) and did not have enough power to assess this association for hip fractures (N= 39) only. Hip fractures contribute the greatest morbidity and mortality among all other osteoporotic fractures. (14) The one-year mortality rate after a hip fracture in women is estimated to range from 17-22%. (14) We conducted a nested case-control study from the Women's Health Initiative
Observational Study (WHI-OS) among 400 cases with physician adjudicated incident hip fractures and 400 age, race, and date of blood draw matched controls. We tested whether high receptor levels of pro-inflammatory cytokines are associated with an increased risk of hip fracture in older women. We focused specifically on the soluble receptors for inflammatory markers as opposed to the markers themselves for the following reasons. In our prior study (13) this association was particularly strong for the soluble receptors of TNF. In addition, increases in 
NESTED CASE-CONTROL DESIGN
The present analyses use a nested case-control design within the prospective design of the WHI-OS. Participants were excluded if they had a prior history of hip fracture at baseline, were currently taking hormones or had taken them up to one year prior to enrollment, or at baseline were taking androgens, selective estrogen receptor modulators, antiestrogens, or other osteoporosis treatments (bisphosphonates, calcitonin). Women without sufficient serum stored or with unknown ethnicity were also excluded leaving a final study group of 39,795 eligible participants. From the eligible women, a total of 404 incident hip fractures occurred. We randomly selected 400 incident hip fractures to comprise the case group. From the remaining without hip fractures, one control per case was selected with individual matching by age at screening (+/-one year), race/ethnicity, and date of blood draw (+/-120 days).
CLINICAL VARIABLES
Current use of personal prescription and over the counter medications was recorded by clinic interviewers by direct inspection of containers. Prescription names were entered into the WHI database and assigned drug codes using Medispan software.
Vitamin and mineral supplements, including usual current supplement doses of elemental calcium and Vitamin D preparations, taken at least twice weekly for the prior two weeks, were entered directly from information on container labels as described above. Dietary intakes of calcium and Vitamin D were also assessed using a semi-quantitative food frequency questionnaire (20 
LABORATORY METHODS
A 12 hour fasting blood sample was obtained at the baseline visit, processed and stored at -80º C according to strict quality control procedures.(24) Stored serum samples were sent to testing laboratories where laboratory personnel were blinded to case-control status for all measurements.
Soluble receptors of interleukin 6 (IL-6 SR) and tumor neurosis factor (TNF SR1 and TNF SR2)
were measured with ELISA (CV% <16%) at the University of Vermont. Sex steroid hormones were measured at the Reproductive Endocrine Research Laboratory at USC, a WHI designated core laboratory. Estradiol and testosterone concentrations were quantified using sensitive and specific RIAs following organic solvent extraction and celite column partition chromatography. (25) (26) (27) (28) For estradiol, the intra-assay and inter-assay CVs were 7.9% and 8-12%, respectively and for testosterone, 6% and 10-12%, respectively. Bioavailable hormone concentrations were calculated using mass action equations. 
STATISTICAL METHODS
Baseline characteristics were compared between hip fracture cases and matched controls, using
McNemar's test for categorical variables and paired t-tests for continuous data. The variables IL-6 SR, TNF SR1 and TNF SR2 were not normally distributed; therefore all these variables were log transformed and subsequently back-transformed to generate geometric means which were reported. Geometric means and standard deviations reported are likely to be smaller than normal calculations involving untransformed data. The reason for this is that the natural log transformation reduces the influence of extreme observations and outliers resulting in exponentiated geometric values that inherit the reduced influence of extreme observations. We For multivariable models, the associations were assessed using conditional logistic regression models to account for the matched case-control design. The odds ratio was used as an approximation of the risk ratio, based on the relative rarity of the outcome incident hip fractures.
To examine the impact of these biomarkers individually we compared women with the lowest cytokine receptor concentrations quartile 1 (Q1) to women with higher concentrations (quartiles points. The variance inflation factor (VIF) was used to test for multicollinearity in multivariable models. VIF values were <2.5 for all covariates indicating that multicollinearity was likely not present in this study.
RESULTS

PARTICIPANT CHARACTERISTICS
The mean age of the subjects was 71 ± 6 .2 years and 95% were white, Table 1 . Hip fracture cases had significantly lower BMI, and physical activity. They were more likely to report corticosteroid use and current smoking compared to controls. In addition, serum levels of 25(OH)D, bioavailable estradiol, and bioavailable testosterone were significantly lower among cases. Conversely, serum cystatin-C levels were significantly higher among cases. The geometric mean inflammatory marker levels of TNF SR1 (p=0.039) and TNF SR2 (p=0.038) were higher among cases versus controls. Also, IL-6 SR was higher for cases compared to controls; however this association was not significant (p=0.280).
Participant characteristics varied by number of high inflammatory markers, Table   2 . Whites were more likely to have a greater number of high inflammatory markers than other ethnicities. A higher number of high inflammatory markers was positively (p trend<0.05) associated with older age, higher BMI, and greater levels of bioavailable estradiol and serum cystatin-C. There was also an inverse association for number of high inflammatory markers with higher physical activity, and better self-reported health. SHBG levels decreased as the number of high inflammatory markers increased, however this association was not significant (p trend=0.09). Bone resorption marker levels, serum 25(OH)D, and bioavailable testosterone levels did not vary by number of high inflammatory markers.
THE ASSOCIATION OF QUARTILES OF INFLAMMATORY MARKERS WITH HIP FRACTURES
There was a lack of a dose-response relationship between increasing quartiles of soluble cytokine receptors and hip fracture risk, 
NUMBER OF HIGH INFLAMMATORY MARKERS AND HIP
FRACTURE
The risk of incident hip fracture was highest among women with 3 "high" levels (quartile 4) of inflammatory markers, Table 3 . In the base analysis, women with 2 or 3 high inflammatory 
DISCUSSION
In this prospective, nested-case-control study, we found that women in the highest quartile for all three of IL-6 SR, TNF SR1 and TNF SR2 had >2 times the risk of hip fracture compared to women with 1 or 0 inflammatory makers in the highest quartile. This risk is roughly equivalent to the risk associated with a one standard deviation decrease in bone mineral density. In our study, the association between serum IL-6 SR and hip fractures was considerable, but not significant. The risk of hip fracture was 43% more likely among participants in the highest IL-6
SR quartile compared to other subjects, but it was not statistically significant.
Our study has a number of strengths. We examined multiple markers of inflammation in relation to incident hip fractures, the most serious consequence of osteoporosis.
We also adjusted for many potential confounders, eliminated hormone users from analysis, and explored several mechanisms of potential mediation underlying this association in order to focus more carefully on this group. There were several limitations in our study. BMD was only measured in 3 WHI clinics, thus we were unable to account for it in our analysis. However, the association of inflammatory markers with incident fractures was independent of BMD in our previous analyses.(13) Also, hip fractures are a rare outcome in our study population affecting approximately 1.01% of women with an annual risk of about 0.14%. This may reflect their relatively young age (age 50-79 years) at enrollment. Among women in a top cytokine soluble receptor quartile, there was an estimated 50% increase in risk, compared to all other women.
Therefore, the absolute risk may have only increased from approximately 0.14% per year to around 0.22% for women in a top inflammatory marker quartile. Our results are primarily generalizable to older Caucasian women. We measured cytokine soluble receptor concentrations in the serum; however these levels may differ in the bone microenvironment and over time.
Serum assays may not reflect local cytokine soluble receptor levels. Several covariates (i.e., physical activity and dietary and supplem entary intake of calcium ) were m easured using selfreport; therefore misclassification as a consequence of recall bias is possible. Finally, residual confounding due to unmeasured factors is a component of all observational studies. In summary, elevated levels of inflammatory markers for all 3 cytokine soluble receptors were associated with an increased risk of hip fractures in older women.
Future clinical trials should test whether interventions to decrease inflammatory marker levels reduces hip fractures. 
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